NEW YORK (GenomeWeb News) – Epigenomics and the Abbott Molecular business of Abbott have expanded their collaboration and amended an earlier licensing deal aimed at developing molecular diagnostic products.
 
The firms began collaborating in September 2007 on development of a colorectal cancer diagnostic based on Epigenomics' intellectual property.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

In a statement, National Institutes of Health Director Francis Collins says sexual harassment is "morally indefensible" and "unacceptable."

Octopuses might owe their intelligence to their liberal alterations to their genes, Cosmos reports.

Stat News and ProPublica report that African Americans are underrepresented in cancer clinical trials.

In Cell this week: genomic analysis of abdominal aortic aneurysm, effect of probiotics on the microbiome, and more.